Primary study · included by 1 review

Efficacy and safety of Omega-3 polyunsaturated fatty acids in adjuvant treatments for colorectal cancer: A meta-analysis of randomized controlled trials.

Liu H 2023 · Liu Haoshuang, Chen Jingfeng, Shao Weihao, et al. · Frontiers in pharmacology · 2023

Included by

The Efficacy and Safety of Nutritional Supplements for Cancer Supportive Care: An Umbrella Review and Hierarchical Evidence Synthesis.

Non-Cochrane · umbrella · 2026 · cited as Liu 2023 · Reference 43; Tables 2-8

Outcome this study informs	Pooled effect	Evidence	Certainty
Body mass index Omega-3 fatty acids (EPA) vs Not reported	BMI MD = NS (4 RCTs, N = 209)	4 studies · 209 participants	GRADE not reported
Weight loss Probiotics (Lactobacillus, Bifidobacterium, Enterococcus or Streptococcus; with or without FOS) plus diet vs Calorie-restricted diet plus placebo, Mediterranean diet only, or placebo	Subgroup analysis by duration of intervention: NS	NR	GRADE not reported
Body weight, goal to prevent weight loss Omega-3 fatty acids (EPA) vs Not reported	Body weight MD = NS (5 RCTs, N = 222)	5 studies · 222 participants	Very low
Quality of life Omega-3 fatty acids (EPA) vs Not reported	QoL (NR): MD = NS (3 RCTs, n = 332)	3 studies · 332 participants	GRADE not reported

1 including review in total.